Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation

BACKGROUND: Haploidentical hematopoietic stem cell transplant (haplo-HSCT) recipients are at high risk for Epstein Barr virus (EBV)-related diseases. EBV-specific CD8(+) cytotoxic T cells can control EBV-infected B cell expansion; however, no studies have investigated EBV-specific immune reconstitut...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ling, Lu, Dao-pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368816/
https://www.ncbi.nlm.nih.gov/pubmed/30736814
http://dx.doi.org/10.1186/s12985-019-1123-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368816/
https://www.ncbi.nlm.nih.gov/pubmed/30736814
http://dx.doi.org/10.1186/s12985-019-1123-y

Ejemplares similares